Qualitek Labs Ltd
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]
- Market Cap ₹ 478 Cr.
- Current Price ₹ 410
- High / Low ₹ 459 / 259
- Stock P/E 59.8
- Book Value ₹ 125
- Dividend Yield 0.00 %
- ROCE 7.49 %
- ROE 6.90 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 77.0% CAGR over last 5 years
- Promoter holding has increased by 2.27% over last quarter.
Cons
- Stock is trading at 3.28 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.97% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Consulting Services
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 6.35 | 11.96 | 19.14 | 29.18 | 45.86 | 67.62 | |
| 5.32 | 9.65 | 13.84 | 21.11 | 34.14 | 51.06 | |
| Operating Profit | 1.03 | 2.31 | 5.30 | 8.07 | 11.72 | 16.56 |
| OPM % | 16.22% | 19.31% | 27.69% | 27.66% | 25.56% | 24.49% |
| 0.02 | 0.05 | 0.18 | 0.08 | 0.15 | 0.20 | |
| Interest | 0.01 | 0.32 | 0.70 | 0.93 | 1.49 | 2.53 |
| Depreciation | 0.35 | 0.50 | 0.84 | 1.40 | 3.27 | 4.63 |
| Profit before tax | 0.69 | 1.54 | 3.94 | 5.82 | 7.11 | 9.60 |
| Tax % | 33.33% | 26.62% | 25.13% | 26.12% | 25.60% | 17.08% |
| 0.46 | 1.14 | 2.94 | 4.31 | 5.28 | 7.96 | |
| EPS in Rs | 460.00 | 24.78 | 5.44 | 5.85 | 5.29 | 6.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 60% |
| 3 Years: | 52% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 77% |
| 3 Years: | 39% |
| TTM: | 51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 9% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | 5.41 | 7.37 | 9.98 | 11.65 |
| Reserves | -0.24 | 1.44 | 4.49 | 25.08 | 75.81 | 134.10 |
| 11.22 | 17.29 | 23.45 | 12.25 | 28.51 | 65.00 | |
| 3.61 | 3.01 | 6.24 | 5.89 | 8.39 | 13.82 | |
| Total Liabilities | 14.60 | 22.20 | 39.59 | 50.59 | 122.69 | 224.57 |
| 6.33 | 7.57 | 13.67 | 29.51 | 40.65 | 52.32 | |
| CWIP | 4.47 | 4.47 | 14.85 | 7.61 | 13.38 | 41.92 |
| Investments | 0.01 | 0.01 | 0.00 | 0.00 | 37.99 | 89.99 |
| 3.79 | 10.15 | 11.07 | 13.47 | 30.67 | 40.34 | |
| Total Assets | 14.60 | 22.20 | 39.59 | 50.59 | 122.69 | 224.57 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 1.35 | -5.12 | 7.22 | 5.54 | 8.01 | 7.15 | |
| -6.07 | -1.73 | -17.41 | -11.61 | -67.49 | -38.72 | |
| 4.82 | 6.74 | 10.51 | 6.14 | 60.77 | 31.89 | |
| Net Cash Flow | 0.10 | -0.11 | 0.33 | 0.06 | 1.29 | 0.32 |
| Free Cash Flow | -4.71 | -6.85 | -10.10 | -4.34 | -12.26 | -31.82 |
| CFO/OP | 171% | -196% | 146% | 71% | 87% | 59% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 68.98 | 66.84 | 111.18 | 98.19 | 93.84 | 106.34 |
| Inventory Days | 11.48 | |||||
| Days Payable | 165.45 | |||||
| Cash Conversion Cycle | 68.98 | 66.84 | 111.18 | 98.19 | 93.84 | -47.63 |
| Working Capital Days | -683.44 | -399.49 | -199.28 | 38.28 | -19.50 | -24.61 |
| ROCE % | 12.33% | 17.78% | 17.30% | 10.82% | 7.49% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of Laboratories Count |
|
|
| Total Employee Headcount Count |
||
| Annual Testing Volume Million Tests |
||
| Collection Centers Count |
||
| Customer Base Count |
||
| Drinking Water Samples (AMRUT Yojna) Count |
||
| National & International Accreditations Count |
||
| Number of PPP and Collaboration Labs Count |
||
| Number of Scientists Count |
||
| Water Samples Tested (Jal Shakti Project) Lacs |
||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Held On June 03Rd, 2026 Under Regulation 30 Of SEBI (LODR) Regulations, 2015
2d - Board approved Rs. 91.31 crore credit facilities from HDFC Bank on June 3, 2026.
-
Intimation Of Appointment Of M/S Finportal Investments Private Limited As Investor Relation (IR) Agency
2 Jun - Qualitek Labs appoints Finportal Investments as IR advisor from 2 June 2026 and sets investor query email.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May - Investor presentation for H2 & FY26 of Qualitek Labs Limited
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
20 May - Submitted H2 FY26 MD&A; FY26 revenue ₹124.52 Cr, PAT ₹14.66 Cr, and FY27 growth guidance.
-
Audited Standalone And Consolidated Financial Results As On 31.03.2026
20 May - Board approved audited FY26 standalone and consolidated results; net profit rose, with unmodified auditor opinion.
Business Profile[1] Qualitek Labs Ltd. (QLL) provides testing, inspection, homologation, certification, and consultancy services to various industries viz automotive, defense, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.